Languages
Telescope Therapeutics leverages human-derived live-cell biosensor platforms and in silico modeling to develop disease-modifying therapies to reshape the chronic fibrotic response leading to organ failure, starting with cardiac fibrosis
A world-class team with deep expertise in GPCRs, enabling us to rediscover and target underexplored GPCRs or location bias for established targets
Taking advantage of our core strengths in cardiology and stem cell biology, we use human iPSC-derived models of fibrosis
Integrating FRET-based biosensors into our platforms allows real-time tracking of critical receptor-dependent signaling events across the cell.